Intellipharmaceutics International Inc. (IPCI)

[mopar44o]

I thought I posted mine but I guess it never went through.

I'm not overly concerned for a few reasons.

1) There should be two more doses of Focalin being approved shortly. This would likely make them cash flow positive on its own or at least very close to it.

2) Someone will correct me if I'm wrong but Focalin is a cyclical drug that seems to sell better during school year. So This and next quarter sales should be better.

3) Oxycodone XR NDA filing is expected to be Q2 2016. I'd expect some sort of agreement prior to that so hopefully an upfront payment of some sort.

4) Company has a track record of being extremely frugal. I think current cash position is expected to last to Q2 so we should be ok for one of those things to happen prior.